Emergent Biosolutions
EBS
172 hedge funds and large institutions have $875M invested in Emergent Biosolutions in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 76 increasing their positions, 55 reducing their positions, and 14 closing their positions.
71% more call options, than puts
Call options by funds: $325K | Put options by funds: $190K
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
38% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 55
7% more capital invested
Capital invested by funds: $818M → $875M (+$57.1M)
3% more funds holding
Funds holding: 167 → 172 (+5)
0.34% more ownership
Funds ownership: 80.44% → 80.77% (+0.34%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$8.66M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8M |
| 3 |
Millennium Management
New York
|
+$5.47M |
| 4 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$3.18M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
-$7.51M |
| 2 |
BC
Broadfin Capital
New York
|
-$7.35M |
| 3 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
-$6.23M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$5.69M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.22M |
EBS Hedge Fund Activity: Q1 2015 in Review
172 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2015, worth a combined $875M — up 7% from $818M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new EBS positions and 14 closed out — a net gain of 6 holders — while 76 added to existing stakes and 55 trimmed.
The largest buyer was Numeric Investors, opening a new position worth an estimated $8.66M. The largest seller was Kingdon Capital Management, cutting an estimated $7.51M.
- 172 institutional investors held Emergent Biosolutions (EBS) as of Q1 2015, up from 167 in Q4 2014.
- Funds reported $875M of Emergent Biosolutions stock for Q1 2015, up 7% quarter-over-quarter.
- 20 funds opened new Emergent Biosolutions positions in Q1 2015 and 14 closed out, a net change of +6 holders.
- The largest Emergent Biosolutions buyer in Q1 2015 was Numeric Investors, an estimated $8.66M added.
- The largest Emergent Biosolutions seller in Q1 2015 was Kingdon Capital Management, an estimated $7.51M sold.
Based on aggregated 13F filings for Q1 2015.